Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens?
Volume 2 Issue 2 , pages 12-17
Received – 8 January 2017, Accepted – 10 January 2017
Daniel Truong M.D.FAAN
The Parkinson and Movement Disorder Institute; Orange Coast Memorial Medical Center, 9940 Talbert Ave, Fountain Valley, CA 92708, USA
Corresponding Author: email@example.com
The causes of dystonia are not fully understood and although currently available treatments can provide effective
Key words: incobotulinumtoxinA, Xeomin®, injection, dystonia